Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

Biotechnology Industry Organization to become Biotechnology Innovation Organization

BIO's new Board Chair, Ron Cohen, CEO of Acorda Therapeutics, announced during Wednesday afternoon's Keynote Luncheon of the 2015 BIO International Convention that the Biotechnology Industry Organization would soon become the Biotechnology Innovation Organization.

Tom Zioncheck, Senior Director of Business Development, Genentech at the BIO Buzz Center 2015

Texas State Representative Zerwas Honored as BIO Legislator of the Year

BIO announced today its selection of Texas State Representative John Zerwas (District 28) as a Legislator of the Year for 2015.

Washington State Senator Parlette Honored as BIO State Legislator of the Year

BIO announces today its selection of Washington State Senator Linda Evans Parlette (R-12) as a state Legislator of the Year for 2015.

New Jersey State Assemblywoman Lampitt Honored as BIO State Legislator of the Year

New Jersey State Assemblywoman Pamela Lampitt (6th District) is a BIO Legislator of the Year for 2015

Tennessee State Representative Sexton Honored as BIO State Legislator of the Year

BIO announces its selection of Tennessee State Representative Cameron Sexton (District 25) as a state Legislator of the Year for 2015.

International BioGENEius Challenge 2015

Overview of the International BioGENEius Challenge at the 2015 BIO International Convention

Marc Boutin, National Health Council CEO, at the 2015 BIO International Convention

CEO Marc Boutin on the National Health Council's work with patients, patient advocacy groups, and other stakeholders to provide a united voice for people with chronic diseases and disabilities.

BIO Releases White Paper Encouraging Industry to Include the Patient Voice Early in Drug Discovery

BIO released a white paper - A Lifecycle Approach to Structured Benefit/Risk Assessment Framework - to encourage companies to incorporate and reflect patient preferences throughout the drug development lifecycle. The white paper release coincides with the BIO International Convention, taking place this week in Philadelphia, Penn.

New White Paper from BIO, NORD, and EY Finds Orphan Drug Tax Credit is Crucial to Rare Disease R&D

Important Legislation Helps More Than 30 Million Americans Suffering From Rare Diseases